Zhang et al. 8 showed that exogenous FGF21 treatment prevented renal lipid accumulation, attenuated inflammation, and decreased oxidative stress in a mouse model of diabetic kidney disease. This evidence concerns the gene FGF21 and diabetic kidney disease.